Home  /  Resource Library  /  Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting

Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting

Study examined the cost effectiveness of the CAR-T therapy tisagenlecleucel in treating diffuse large b-cell lymphoma.